FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Clinical trial NCT06669117 · RECRUITING
Trial details
- NCT number
- NCT06669117
- Sponsor
- Pierre Fabre Medicament
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2030-10-21
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.